Market Research Reports

Preventive Healthcare Technologies and Services Market (Early Detection and Screening Technologies, Prophylaxis Technologies, Advanced Technologies to Reduce Errors and Chronic Disease Management Technologies) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

102pages
Published Date: 2014-07-29
 

Description


This report on preventive healthcare technology and services market studies current as well as future prospects of the market globally. Preventive healthcare technologies and services market is a combination of screening, monitoring, prophylaxis and healthcare information technology having single target of disease prevention. These technologies aid in prevention of diseases by predetermination of the disease or immunization. Preventive healthcare technologies and services are high in demand owing to rising incidences of cardiovascular diseases, chronic respiratory diseases, dispensing or prescription errors, diabetes and certain infectious diseases. This report comprises an elaborate executive summary, which includes a market snapshot that provides overall information of various segments and sub-segments that are contained in the report. It also provides an overall information and data analysis of the global preventive healthcare technology and services market with respect to market segments based on technologies, services as well as geographic regions.

Preventive healthcare technologies and services market is segmented as early detection and screening technologies, prophylaxis technologies, advanced technologies to reduce errors and chronic disease management technologies. The early detection and screening technologies are further segmented as personalized medicine, automated screening technology and other advanced screening technologies. The prophylaxis market comprises influenza vaccine, meningococcal vaccine, combined tetanus-diphtheria-pertussis vaccine, human papillomavirus vaccine and other new vaccines. Advanced technologies include electronic prescribing, computerized provider order entry systems, clinical decision support systems, automated prescription, formulation and dispensing technology, smart infusion pumps and smart packaging. The chronic disease management technologies contain blood pressure monitors, glucose monitors, cardiac monitors and asthma monitors. The market for early detection and screening technologies has been analyzed based on applications of the technology, global sales of screening devices, integrated market study of personalized medicine and their geographic distribution. 

The market for prophylaxis technologies has been analyzed based upon the prevalence of disease, distribution of vaccines to governmental and non-governmental bodies, pricing strategies, pipeline drugs and geographical distribution. The advanced technologies to reduce errors market has been analyzed based upon the installation patterns and costs, maintenance costs, importance of customized systems and its global market penetration. The chronic disease management technologies has been analyzed based upon the prevalence of chronic diseases, market differentiation on the basis of self-monitoring devices and commercial devices, price and geographical distribution. The market size and forecast in terms of USD million for each technology and service has been provided for the period 2012 to 2020. The report on preventive healthcare technologies and services market also provides % compounded annual growth rate (CAGR) for each market segment for the forecast period 2014 to 2020, considering 2013 as the base year.

Geographically, preventive healthcare technologies and services market has been categorized into four major regions: North America, Europe, Asia-Pacific, and Rest of the World (ROW). The market size and forecast for each of these regions have been provided for the period 2012 to 2020 along with CAGR (%) for the forecast period 2014 to 2020. The research study also incorporates competitive scenario in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global preventive healthcare technologies and services market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis and Porter’s five forces analysis, and key player’s market share analysis in 2013 for the preventive healthcare technologies and services market. 

A list of recommendations has been provided for new entrants to help establish strong presence and for existing market players to increase market share. The report also profiles major players in the preventive healthcare technologies and services market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players profiled in this report include Omron Healthcare, Inc., Medtronic, Inc., Alere, Inc., Healthways, Inc., Dilon Technologies, Inc., Merck&Co. Inc. and ScriptPro LLC.

Global Preventive Healthcare Technologies and Services Market
  • Early Detection and Screening Technologies
    • Personalized Medicine
    • Automated Screening
    • Other Advanced Screening Tests
    • Prophylaxis Technologies
  • Flu vaccines
    • Meningococcal Vaccines
    • Combined Tetanus-Diptheria-Pertussis Vaccines
    • Human Papillomavirus Vaccine
    • Other new Vaccines
  • Advanced Technologies to Reduce Errors
    • Electronic Prescribing
    • Computerized Provider Order Entry Systems
    • Clinical Decision Support System
    • Automated Prescription, Formulation and Dispensing
    • Smart Infusion Pumps
    • Smart Packaging
  • Chronic Disease Management Technologies
    • Blood Pressure Monitors
    • Glucose Monitors
    • Cardiac Monitors
    • Asthma Monitors
Global Preventive Healthcare Technologies and Services Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents



Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Sources
1.4 Assumptions

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Preventive Healthcare Technologies and Services Market (2012 & 2019)
2.2 Global Preventive Healthcare Technologies and Services Market, by Segments, 2012 (USD Million)
2.3 Comparative Analysis: Global Preventive Healthcare Technologies and Services Market, By Geography, 2013 & 2020 (Value %)

Chapter 3 Global Preventive Healthcare Technologies and Services Market Overview
3.1 Introduction and Market Definition
3.2 Market Dynamics
      3.2.1 Drivers
               3.2.1.1 Constructive government policies for development of healthcare information technology market
               3.2.1.2 Increasing public awareness about prophylaxis or vaccination with support of government and non-government organizations
               3.2.1.3 Technological up gradation with respect to information technology would aid to reduce healthcare cost burden
               3.2.1.4 Patients suffering from chronic diseases found a prudential alternative in form of self-monitoring devices for disease management
      3.2.2 Restraints
               3.2.2.1 High installation and maintenancecosts of healthcare IT solutions have lowered the pace of market penetration in emerging economies
               3.2.2.2 Deficient patient engagement activities which impedes the physician’s and pharmacist’s motivation for adoption of preventive healthcare technologies
      3.2.3 Market Opportunities
               3.2.3.1 Revised cost structure for emerging markets would assist the growth of Healthcare IT solutions
               3.2.3.2 Alliance of government and preventive healthcare service providing organizations would aid the market penetration
3.3 Porter’s Five Force Analysis of the Global Preventive Healthcare Technologies and Services Market
      3.3.1 Bargaining power of suppliers
      3.3.2 Bargaining power of buyers
      3.3.3 Threat of substitutes
      3.3.4 Threat of new entrants
      3.3.5 Competitive rivalry
3.4 Market Attractiveness Analysis: Global Preventive Healthcare Technologies and ServicesMarket, by Geography
3.5 Competitive Landscape (Heat Map Analysis of Key Market Players)
      3.5.1 Heat Map Analysis of the Preventive Healthcare Technologies and Services Market, by Key Market Players, 2013

Chapter 4 Preventive Healthcare Technologies and Services Market, by Technologies and Products
4.1 Overview
4.2 Early Detection and Screening Technologies
      4.2.1 Personalized Medicine
               4.2.1.1 Global Personalized Medicine Market Revenue, 2012 - 2020 (USD Million)
      4.2.2 Automated Screening
               4.2.2.1 Global Automated Screening Market Revenue, 2012 - 2020 (USD Million)
      4.2.3 Other Advanced Screening Technology
               4.2.3.1 Global Other Advanced Screening Technology Market Revenue, 2012 - 2020 (USD Million)
4.3 Prophylaxis Technologies
      4.3.1 Influenza Vaccine
               4.3.1.1 Global Influenza Vaccine Market Revenue, 2012 - 2020 (USD Million)
      4.3.2 Meningococcal Vaccine
               4.3.2.1 Global Meningococcal Vaccine Market Revenue, 2012 - 2020 (USD Million)
      4.3.3 Combined Tetanus-Diptheria-Pertussis Vaccine
               4.3.3.1 Global Combined Tetanus-Diphtheria-Pertussis Vaccine Market Revenue, 2012 - 2020 (USD Million)
      4.3.4 Human Papillomavirus Vaccine
               4.3.4.1 Global Human Papillomavirus Vaccine Market Revenue, 2012 - 2020 (USD Million)
      4.3.5 Other New Vaccines
               4.3.5.1 Global Other New Vaccines Market Revenue, 2012 - 2020 (USD Million)
4.4 Advanced Technologies to Reduce Errors
      4.4.1 Electronic Prescribing
               4.4.1.1 Global Electronic Prescribing Market Revenue, 2012 - 2020 (USD Million)
      4.4.2 Computerized Provider Order Entry Systems
               4.4.2.1 Global Computerized Provider Order Entry (CPOE) Systems Market Revenue, 2012 - 2020 (USD Million)
      4.4.3 Clinical Decision Support System
               4.4.3.1 Global Clinical Decision Support System (CDSS) Market Revenue, 2012 - 2020 (USD Million)
      4.4.4 Automated Prescription, Formulation and Dispensing
               4.4.4.1 Global Automated Prescription, Formulation and Dispensing Systems Market Revenue, 2012 - 2020 (USD Million)
      4.4.5 Smart Infusion Pumps
               4.4.5.1 Global Smart Infusion Pumps Market Revenue, 2012 - 2020 (USD Million)
      4.4.6 Smart Packaging
               4.4.6.1 Global Smart Packaging Market Revenue, 2012 - 2020 (USD Million)
4.5 Chronic Disease Management Technologies
      4.5.1 Blood Pressure Monitors
               4.5.1.1 Global Blood Pressure Monitors Market Revenue, 2012 - 2020 (USD Million)
      4.5.2 Glucose Monitors
               4.5.2.1 Global Glucose Monitors Market Revenue, 2012 - 2020 (USD Million)
      4.5.3 Asthma Monitors
               4.5.3.1 Global Asthma Monitors Market Revenue, 2012 - 2020 (USD Million)
      4.5.4 Cardiovascular Monitors
               4.5.4.1 Global Cardiovascular Monitors Market Revenue, 2012 - 2020 (USD Million)

Chapter 5 Preventive Healthcare Technologies and Services Market, by Geography
5.1 Overview
      5.1.1 Global Preventive Healthcare Technologies and Services Market Revenue, by Geography, 2012 - 2020 (USD Million)
5.2 North America
      5.2.1 North America Preventive Healthcare Preventive Technologies and Services Market Revenue, 2012 - 2020 (USD Million)
5.3 Europe
      5.3.1 U.K. Healthcare Expenditure (USD Million), 2001-2011
      5.3.2 Europe Preventive Healthcare Technologies and Services Market Revenue, 2012 - 2020 (USD Million)
5.4 Asia-Pacific
      5.4.1 Asia-Pacific Preventive Healthcare Preventive Technologies and Services Market Revenue, 2012 - 2020 (USD Million)
5.5 Rest of the World (RoW)
      5.5.1 Rest of the World (RoW) Preventive Healthcare Preventive Technologies and Services Market Revenue, 2012 - 2020 (USD Million)

Chapter 6 Recommendations
6.1 Emerging economies highly investing in preventive healthcare services along with adoption of novel technologies from North America and Europe
6.2 Proteomics and genomics are the emerging markets of biotechnology aiding the growth of personalized medicine
6.3 Up-gradation of hospitals and pharmacies with assistance of healthcare information technology

Chapter 7 Company Profiles
7.1 Alere, Inc.
      7.1.1 Company Overview
      7.1.2 Financial Overview
      7.1.3 Product Portfolio
      7.1.4 Business Strategies
      7.1.5 Recent Developments
7.2 Dilon Technologies, Inc.
      7.2.1 Company Overview
      7.2.2 Financial Overview
      7.2.3 Product Portfolio
      7.2.4 Business Strategies
      7.2.5 Recent Developments
7.3 Healthways, Inc.
      7.3.1 Company Overview
      7.3.2 Financial Overview
      7.3.3 Product Overview
      7.3.4 Business Strategies
      7.3.5 Recent Developments
7.4 Medtronic, Inc.
      7.4.1 Company Overview
      7.4.2 Financial Overview
      7.4.3 Product Portfolio
      7.4.4 Business Strategies
      7.4.5 Recent Developments
7.5 Merck & Co., Inc.
      7.5.1 Company overview
      7.5.2 Financial overview
      7.5.3 Product portfolio
      7.5.4 Business Strategies
      7.5.5 Recent Developments
7.6 Omron Healthcare, Inc.
      7.6.1 Company Overview
      7.6.2 Financial Overview
      7.6.3 Product Portfolio
      7.6.4 Business Strategies
      7.6.5 Recent Developments
7.7 ScriptPro LLC
      7.7.1 Company Profile
      7.7.2 Financial Overview
      7.7.3 Product Portfolio
      7.7.4 Business Strategies
      7.7.5 Recent Developments

List of Figures

FIG. 1 Preventive Healthcare Technologies and Services: Market Segmentation
FIG. 2 Global Preventive Healthcare Technologies and Services Market, 2012 (USD Million)
FIG. 3 Comparative Analysis: Global Preventive Healthcare Technologies and Services Market, by Geography, 2013 & 2020 (Value %)
FIG. 4 Porter’s Five Forces Analysis: Global Preventive Healthcare Technologies and Services Market
FIG. 5 Market Attractiveness Analysis: Global Preventive Healthcare Technologies and Services Market, by Geography
FIG. 6 Heat Map Analysis of Key Market Players of the Preventive Healthcare Technologies and Services Market
FIG. 7 Global Personalized Medicine Market Revenue, 2012 - 2020 (USD Million)
FIG. 8 Global Automated Screening Market Revenue, 2012 - 2020 (USD Million)
FIG. 9 Global Other Advanced Screening Technology Market Revenue, 2012 - 2020 (USD Million)
FIG. 10 Global Influenza Vaccine Market Revenue, 2012 - 2020 (USD Million)
FIG. 11 Global Meningococcal Vaccine Market Revenue, 2012 - 2020 (USD Million)
FIG. 12 Global Combined Tetanus-Diphtheria-Pertussis Vaccine Market Revenue, 2012 - 2020 (USD Million)
FIG. 13 Global Human Papillomavirus Vaccine Market Revenue, 2012 - 2020 (USD Million)
FIG. 14 Global Other New Vaccines Market Revenue, 2012 - 2020 (USD Million)
FIG. 15 Global Electronic Prescribing Market Revenue, 2012 - 2020 (USD Million)
FIG. 16 Global Computerized Provider Order Entry (CPOE) Systems Market Revenue, 2012 - 2020 (USD Million)
FIG. 17 Global Clinical Decision Support System (CDSS) Market Revenue, 2012 - 2020 (USD Million)
FIG. 18 Global Automated Prescription, Formulation and Dispensing Systems Market Revenue, 2012 - 2020 (USD Million)
FIG. 19 Global Smart Infusion Pumps Market Revenue, 2012 - 2020 (USD Million)
FIG. 20 Global Smart Packaging Market Revenue, 2012 - 2020 (USD Million)
FIG. 21 Global Blood Pressure Monitors Market Revenue, 2012 - 2020 (USD Million)
FIG. 22 Global Glucose Monitors Market Revenue, 2012 - 2020 (USD Million)
FIG. 23 Global Asthma Monitors Market Revenue, 2012 - 2020 (USD Million)
FIG. 24 Global Cardiovascular Monitors Market Revenue, 2012 - 2020 (USD Million)
FIG. 25 North America Preventive Healthcare Technologies and Services Market Revenue, 2012 - 2020 (USD Million)
FIG. 26 Europe Preventive Healthcare Technologies and Services Market Revenue, 2012 - 2020 (USD Million)
FIG. 27 Asia-Pacific Preventive Healthcare Technologies and Services Market Revenue, 2012 - 2020 (USD Million)
FIG. 28 Rest of the World (RoW) Preventive Healthcare Technologies and Services Market Revenue, 2012 - 2020 (USD Million)
FIG. 29 Alere: Annual Sales Revenue, 2010 – 2012 (USD Million)
FIG. 30 Healthways, Inc.: Annual Sales Revenue, 2010 – 2012 (USD Million)
FIG. 31 Medtronic, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 32 Merck & Co., Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 33 Omron Healthcare, Inc.: Annual Sales,2011 – 2013 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Preventive Healthcare Technologies and Services Market (2012 & 2019)
TABLE 2 Global Preventive Healthcare Technologies and Services Market, 2012 – 2020 (USD Million)
TABLE 3 Global Early Detection and Screening Technologies Market, 2012 – 2020 (USD Million)
TABLE 4 Global Prophylaxis Technologies Market, 2012 – 2020 (USD Million)
TABLE 5 Global Advanced Technologies to Reduce Errors Market, 2012 – 2020 (USD Million)
TABLE 6 Global Chronic Disease Management Technologies Market, 2012 – 2020 (USD Million)
TABLE 7 Global Preventive Healthcare Technologies and Services Market Revenue, by Type, 2012 – 2020 (USD Million)
TABLE 8 U.K. Healthcare Expenditure (USD Million), 2001-2011

Enquiry Before Buying


Free Market Analysis


Preventive healthcare comprises measures taken for prevention of disease by predetermination of the disease or immunization. The diseases that are monitored or immunized vastly are cardiovascular disease, chronic respiratory disease, accidental complications, diabetes and certain infectious diseases. In the modern era, preventive healthcare is attributed with technology that aids significant growth in its application range and efficiency. A decade old revolution of information technology has also influenced the healthcare market and primarily contributed in the market growth of preventive healthcare technology and services market globally.

The preventive healthcare technologies and services market is segmented as early detection and screening technologies, prophylaxis technologies, advanced technologies to reduce errors and chronic disease management technologies. In 2013, early detection and screening technologies accounted for the highest market share, while the market for advanced technologies to reduce errors is expected to be the fastest growing market segment during the forecast period. Early detection and screening technologies market is further sub-segmented into personalized medicine, automated screening techniques and other automated screening techniques. Personalized medicine was observed to be the largest sub-segment in this category, with the increasing research on proteomics and genomics, being the vital reason for its growth in the coming years.

Constructive government policies that are providing favorable environment for healthcare information technology and increasing awareness and initiatives for prophylaxis are major reasons that are driving the growth of this market. Similarly, reduced healthcare cost burden due to penetration of healthcare information technology and increasing demand for self-monitoring devices are other key factors anticipated to propel the market growth. However, high installation and maintenance costs have hindered the penetration of preventive technologies in the emerging markets of the world. Deficient patient engagement activities have demotivated the physicians and pharmacists to adopt the technology. 

Geographical scenario of preventive healthcare technologies and services market depicts the market revenue, size and forecast for North America, Europe, Asia-Pacific and Rest of the World. In year 2013, North America was observed to be the largest and fastest growing market during the forecast period of 2014 to 2020 for preventive healthcare technologies and services. The supportive reimbursement policies, international hub of information technology, high awareness about preventive healthcare technologies and presence of major players in this market are some of the major factors supporting the growth of this market in North America. Some of the technologies such as electronic prescribing, clinical decision support system and automated prescription, formulation and dispensing are at nascent stage and expected to affect the market significantly after the entry, hence the other geographies especially Asia-Pacific and Rest of the World are anticipated to be potential markets in the future, with the current market penetration estimated to be low.

The preventive healthcare technologies and services market is very dynamic and the key players of this market can be differentiated on the basis of segments. In early detection and screening market major players includes Dilon Technologies, Inc., Myraid Genetics, Inc., Novx Systems, Inc., U-Systems, inc. and Viatronix, Inc. Sanofi Pasteur MSD, Merck & Co. and GlaxoSmithKline plc are the key players operating in Prophylaxis segment, whereas advanced technologies to reduce errors segment includes players such as Lifecom, Inc., ScriptPro LLC and Omnicell, Inc. Chronic disease management technologies segment include Alere, Healthways, Inc., Omron Healthcare, Inc. and Medtronic, Inc, as the key players in this segment of the market.

preventive-healthcare-technologies

 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research